scispace - formally typeset
Search or ask a question

Do people with Alzheimer's have compromised immune systems? 

Answers from top 10 papers

More filters
Papers (10)Insight
Altogether, these data indicate that in AD the immune tolerance to Aβ is compromised leading to chronic immune/inflammatory responses against Aβ that are detrimental and cause neuropathology.
Currently, there is little doubt that the immune system plays a role in the neurodegenerative process in Alzheimer's disease (AD).
The dramatic difference in the presence of such antibodies in normal versus Alzheimer's disease (AD) suggests an important immune system dysfunction in AD.
Journal ArticleDOI
David A. Lawrence, Dongsoo Kim 
17 Jan 2000-Toxicology
65 Citations
Inversely, aberrant immune system activities could lead to pathologies associated with altered nervous activities, such as Alzheimer's disease, chronic fatigue, or multiple sclerosis.
The immune system may play an important role in the neurodegenerative process in Alzheimer's disease (AD).
Thus, Alzheimer's disease, atherosclerosis, type II diabetes and some autoimmune disorders are linked to changes in immune function.
We conclude that the prevalence of celiac disease in Alzheimer's disease is not higher than in cognitively unimpaired elders, suggesting that the immune changes in celiac disease are unlikely to play a role in Alzheimer's disease.
These results demonstrate the existence of defective cellular immune functions in both elderly Down's patients and Alzheimer's patients.
This immune dysregulation may affect conditions associated with chronic inflammation, such as atherosclerosis and Alzheimer's disease.
The results add further support to the concept that inflammation and similar immune mechanisms may contribute to Alzheimer's disease pathogenesis.

Related Questions

How does alcohol consumption impact the immune system, leading to neutrophil dysfunction in Alcoholic Hepatitis patients?10 answersAlcohol consumption significantly impacts the immune system, leading to various dysfunctions, including neutrophil dysfunction, particularly in patients with Alcoholic Hepatitis (AH). Chronic excessive alcohol consumption causes Alcoholic Liver Disease (ALD), which encompasses a spectrum of liver injuries, including AH, characterized by an inflammatory response where immune cells play a crucial role. Patients with AH exhibit immune dysfunction, with studies showing altered mitochondrial function in immune cells, which is critical for their responses and regulates senescence, further contributing to immune dysfunction. The metabolism of alcohol produces toxic metabolites like acetaldehyde and reactive oxygen species, which, along with alcohol-induced dysbiosis and increased intestinal permeability, promote the translocation of bacterial products. This translocation exacerbates the production of inflammatory cytokines in the liver, perpetuating local inflammation and contributing to the progression of ALD. Alcohol alters both innate and adaptive immune cells, including neutrophils, macrophages, B cells, and T cells, leading to immune dysfunction associated with alcohol-induced end-organ damage. Chronic alcohol consumption affects circulating and tissue-resident myeloid cells, dampening acute drinking but enhancing chronic drinking's production of inflammatory mediators. In AH, the immune system is hyperactive yet dysfunctional, with alterations in immune checkpoints (ICPs) that could relate to the dysregulated state, affecting the functionality of immune cells including neutrophils. Specifically, patients with severe AH have dysfunctional NK cells and CD8 T cells, which fail to kill target cells, including monocytes, due to downregulated receptors necessary for cytotoxic cell recognition, indicating a broader immune dysfunction that likely includes neutrophil impairment. Alcohol dysregulates the function of lymphocytes, neutrophils, monocytes, and tissue macrophages, contributing to systemic inflammation, oxidative stress, mitochondrial dysfunction, and fibrosis in ALD and AH. Furthermore, the neutrophil-to-lymphocyte ratio (NLR) has been associated with infection, acute kidney injury (AKI), and the severity of alcoholic hepatitis, indicating that neutrophil dysfunction plays a significant role in the disease's progression and outcome. Lastly, acute alcoholic hepatitis is characterized by profound immune dysfunction, with evidence of impaired microbial defense, where neutrophils exhibit reduced phagocytic capacity and oxidative burst. This comprehensive view from multiple studies underscores the multifaceted impact of alcohol consumption on the immune system, leading to neutrophil dysfunction among other immune impairments in AH patients.
What is the role of inflammation in the development and progression of Alzheimer's disease?4 answersIn Alzheimer's disease (AD), inflammation plays a crucial role in both development and progression. Neuroinflammation, triggered by the accumulation of Aβ and tau proteins, leads to the activation of microglia and astrocytes, releasing pro-inflammatory cytokines and reactive species that contribute to neuronal damage and synaptic loss. Chronic peripheral inflammation, as well as acute inflammatory insults like infections, critical illness, and surgery, have been linked to AD risk, highlighting the systemic impact of inflammation on the brain. While some anti-inflammatory treatments have shown promise in attenuating AD progression, challenges remain in finding effective therapies targeting inflammatory mechanisms to prevent or reverse the disease. Efforts focusing on resolving inflammation post-acute insults may hold potential in preserving brain health and limiting neurodegenerative pathology in AD.
Is Alzheimer’s disease infectious?4 answersAlzheimer's disease (AD) is a neurodegenerative disease characterized by the deposition of amyloid-β plaques and neurofibrillary tangles. There is growing evidence suggesting that infections may play a role in AD pathogenesis. Pathogens such as viruses, bacteria, and fungi have been detected in the brains of AD patients and are known to promote the development of AD pathology. However, the role of infections in AD remains controversial. Some studies suggest that prior infection is associated with a higher risk of AD, while others show a lower overall cancer risk in individuals with a history of infection. The presence of microorganisms in the brain tissue of AD patients, such as herpes simplex virus type 1 (HSV1) and periodontal pathogens, has been linked to neuroinflammation and neurodegeneration. Further research is needed to fully understand the relationship between infections and AD.
How does kidney disease affect the immune system?4 answersKidney disease affects the immune system by causing immune system dysregulation and metabolic disturbances. This dysregulation involves a complex interplay between various immune cell types, cytokines, chemokines, and complement factors, which can trigger kidney inflammation and tissue injury. Chronic kidney disease (CKD) is characterized by immune dysfunction, including impairment of both innate and adaptive immune systems, as well as other factors such as uremia, malnutrition, chronic inflammation, mineral bone disease, and anemia. In CKD patients, there is an altered immune response, increased susceptibility to infections, virus-associated cancers, and impaired response to vaccination. Additionally, T-helper type 17 (Th17) cells and regulatory T (Treg) cells play important roles in immune dysregulation in CKD patients. The presence of certain T cell subsets at the time of renal transplantation may also affect the immune response and graft function.
Why are cancer patients exposed to a weak immune system?5 answersCancer patients are exposed to a weak immune system due to several factors. Firstly, the immune system declines with age, and most cancers emerge in the elderly. Additionally, individuals with primary immune deficiencies have a higher risk of developing cancer, indicating the importance of a functional immune system in cancer prevention. Furthermore, cancer itself can alter the immune system, as tumor cells can release substances that suppress immune responses and promote tumor growth. Moreover, cancer patients receiving immunotherapy may be at a higher risk of an aberrant immune response in case of infection, highlighting the delicate balance of the immune system in cancer patients. Overall, the complex nature of cancer and its interaction with the immune system contribute to the weakened immune response observed in cancer patients.
Who are at risk in alzheimer's disease?5 answersRisk factors for Alzheimer's disease (AD) include biologic (e.g. vascular), economic, and socio-cultural factors. AD incidence and prevalence has been linked to race, and African American/Black individuals (AA/B) are at greater risk compared to non-Hispanic Whites (NHW), due to physiological and social factors, however few clinical research studies are dedicated to prospective and thoughtful data collection on both physiology (biomarkers) and social/structural risk factors, including discrimination. Older adults are more at risk for AD, and risk factors such as sleep disruption, depression, and motor function are implicated. Cerebrospinal fluid parameters for biomarkers of tau and amyloid-β (Aβ) were universally lower among Blacks compared with Whites, raising concern that norm reference may not be accurate for all populations. Other associated factors such as sex, poor nutrition, education, impaired functional status, body mass index, diabetes, smoking, alcohol, fish intake, and pesticide exposure have also been reported, though none are clear. Implementing evidence-based strategies to address modifiable risk factors can help reduce the risk for Alzheimer's disease and related dementias.

See what other people are reading

What is the effect of diabetes mellites drugs on il6?
5 answers
Diabetes mellitus drugs have varying effects on IL-6 levels. Metformin, commonly used in type 2 diabetes treatment, activates AMPK, leading to increased production of SHP and regulation of IL-6-induced hepatic insulin resistance. In contrast, insulin therapy in type 2 diabetes patients is associated with significantly higher IL-6 serum levels compared to metformin-based therapies, indicating a pro-inflammatory impact. Additionally, interventions targeting IL-6 signaling pathways, such as anti-IL-6 (siltuximab) or anti-IL-6 receptor (tocilizumab) therapies, show distinct effects on T cell function and immune responses in individuals with type 1 diabetes, suggesting differential outcomes based on the specific molecular target of the intervention. Overall, the choice of diabetes medication can influence IL-6 levels and subsequent inflammatory responses in diabetic patients.
Nigericin causes cells to undergo pyroptosis and this is characterised by?
5 answers
Nigericin induces pyroptosis in cells, characterized by the activation of Caspase-1/GSDMD-mediated pyroptosis and Caspase-3-mediated apoptosis, leading to cell death. This process involves mitochondrial dysfunction, mitochondrial ROS production, and cellular potassium efflux triggered by nigericin, resulting in the activation of T cells and amplification of the anti-tumor immune response. Additionally, nigericin-induced pyroptosis is associated with ribosome stalling, depletion of cytosolic potassium ions, and activation of the ribotoxic stress response (RSR) sensor kinase ZAKɑ, p38, and JNK. Furthermore, nigericin-induced pyroptosis in primary effusion lymphoma (PEL) cells involves mitochondrial dysfunction, caspase-9-mediated apoptosis, and down-regulation of Wnt/β-catenin signaling. Overall, nigericin-induced pyroptosis is a complex process involving multiple molecular pathways and cellular responses.
What does CX3CL1 do ?
4 answers
CX3CL1, also known as Fractalkine, plays a crucial role in various biological processes. It has been found to induce migration, movement, and invasion of oral squamous cell carcinoma cells through the CX3CR1 pathway, promoting tumour motility. Additionally, CX3CL1 has been associated with different cancer types, showing differential expression levels and correlations with clinical features, suggesting its potential as a prognostic marker and immunotherapy target. In neurodegenerative diseases, CX3CL1 modulates microglia activation, neuroprotection, and phagocytosis, influencing disease progression and neuronal degeneration. Moreover, under hypoxic conditions, CX3CL1/CX3CR1 signaling mediates M1-type microglial polarization, leading to synaptic loss in the hippocampus and memory impairment. Overall, CX3CL1's functions span from cancer progression and immune responses to neuroinflammation and neurodegeneration.
What are some recommended supplements for a healthy pregnancy?
5 answers
During pregnancy, recommended supplements for a healthy pregnancy include folic acid, iron, calcium, vitamin D, omega-3 fatty acids, and multiple micronutrients. Folic acid is crucial for maternal and fetal health, aiding in the prevention of birth defects. Iron supplementation is essential to prevent anemia and support optimal fetal development. Additionally, omega-3 fatty acids, particularly eicosapentaenoic acid and docosahexaenoic acid, are favored for high-risk pregnancies. Vitamin D is vital for immune function and bone health, while calcium supports bone development in the fetus. Multiple micronutrient supplementation has shown significant effects on maternal and fetal health, potentially impacting clinical practice positively. Ensuring adequate intake of these supplements can reduce the risk of pregnancy complications and promote overall maternal and fetal well-being.
What is the research gap in immunohistochemical markers in potentially malignant oral disorders and oral malignancies?
5 answers
The research gap in immunohistochemical markers in potentially malignant oral disorders and oral malignancies lies in the need for a comprehensive understanding and classification of markers to aid in early diagnosis and precision therapy. Studies have highlighted the significance of markers like S100A7, T regulatory cells (Treg), CD8+ effector T cells (Teff), Paxillin, Melanoma inhibitory activity (MIA), and MIA2 in identifying dysplastic lesions, disease progression, and potential therapeutic targets. However, there is a lack of qualitative evidence and a conceptual framework for beginners in the field of immunohistochemistry, hindering the interpretation and comparison of markers in oral diseases. Further research is needed to establish a standardized classification system based on cell lineage, tissue, and site of expression to facilitate better marker understanding and application in research and clinical practice.
What are the current methods used for survival prediction in AML (Acute Myeloid Leukemia)?
5 answers
Survival prediction in Acute Myeloid Leukemia (AML) involves various methods based on different factors. One approach is utilizing the Charlson Comorbidity Index (CCI) score as an adjunctive measure to predict survival in AML patients undergoing chemotherapy outside of clinical trials, stratified by treatment regimen. Another method involves developing a prognostic risk scoring model using differentially expressed genes to quantitatively predict prognosis in AML patients, showing effectiveness in predicting outcomes in different AML cohorts. Additionally, a prognostic model for survival in older/unfit AML patients treated with lower-intensity chemotherapy regimens has been proposed, considering various adverse factors associated with survival and incorporating molecular mutation profiles for improved prognostic accuracy. Furthermore, a reliable prognostic risk model based on immune-related genes has been established to enhance prognostic evaluation and personalized treatment recommendations for AML patients, reflecting the immune microenvironment of the disease.
Which are the roles of NRP1?
5 answers
Neuropilin-1 (NRP1) plays diverse roles in various biological processes and diseases. In head and neck squamous cell carcinoma (HNSCC), NRP1 acts as a crucial biomarker associated with proliferation, metastasis, and immunosuppression, suggesting its potential as an immunoregulation target and predictive biomarker in immune treatment. In multiple cancer types, NRP1 is implicated in tumor development, immunity, and prognosis, with high expression levels correlating with poor outcomes and influencing tumor mutational burden and immune cell infiltration. Additionally, NRP1 promotes adipogenesis by interacting with JIP4 and activating the Akt and ERK1/2 pathway, with glycosylation negatively affecting this process. Moreover, a splice variant of NRP1 enhances colorectal cancer metastasis by modulating endosomal signaling pathways, promoting cell migration, invasion, and metastasis. In prostate cancer, NRP1 interacts with EGFR to activate the AKT signaling pathway, driving malignant progression and suggesting a potential therapeutic target.
What is gamma in camera?
4 answers
A gamma camera is a crucial tool in nuclear medicine that utilizes gamma or x-ray radiation to create diagnostic images of metabolically active areas, organ function, blood flow in the heart muscle, bone growth, tumor detection, and various medical studies. It consists of a detector array with pixels generating signals from incident radiation, collimators to focus radiation onto detector pixels, an actuator for precise movement, and a processor for image data generation with sub-pixel resolution. In autoimmune diseases, nuclear medicine techniques play a significant role in evaluating disease activity, offering sensitive modalities for diagnosis and therapy decision-making, using specific radiopharmaceuticals to understand immune processes and aid in therapy selection. Advanced gamma cameras based on dual-detector technology integrate visible light and radiation images for accurate registration and fusion, enabling high-resolution energy spectrum analysis and nuclide identification.
What is the toxicity of E. Tirucalli?
5 answers
The toxicity of Euphorbia tirucalli (E. tirucalli) varies based on the study conducted. Research indicates that the plant extract did not exhibit toxicity in terms of reducing tumor growth or causing toxic effects in mice when administered orally at specific doses. However, another study found that high concentrations of aqueous extracts of E. tirucalli induced genotoxicity and cytotoxicity in human leukocytes, potentially affecting DNA damage and cell viability. Additionally, the acetone extract of E. tirucalli stem bark showed toxicity against harmful snails, affecting their biochemical profiles and demonstrating toxic effects in an experimental pond setting. Overall, while E. tirucalli did not show antimicrobial, hepato, or nephrotoxic effects, it exhibited some cytotoxic and genotoxic properties in certain contexts.
How does inflammation in rheumatoid arthritis contribute to cardiovascular disease?
4 answers
In rheumatoid arthritis (RA), chronic inflammation significantly contributes to cardiovascular disease (CVD) risk. The inflammatory state in RA leads to enhanced atherogenesis, increasing the risk of CVD events such as myocardial infarction and stroke. Systemic inflammation, along with traditional risk factors like hypertension and dyslipidemia, accounts for nearly 50% of the total CVD risk in RA patients. Studies have shown that markers like homocysteine, asymmetric dimethylarginine, and carotid intima–media thickness are correlated with cardiovascular risk in RA. Biologic disease-modifying antirheumatic drugs (bDMARDs) have been effective in controlling inflammation, reducing CVD risk, and stabilizing atherosclerotic plaques in RA patients. Early detection of atherosclerosis and targeted anti-inflammatory therapies are crucial in managing cardiovascular risk in RA patients.
Cancer associated antigens?
5 answers
Cancer-associated antigens play a crucial role in cancer immunotherapy. These antigens can be broadly categorized into aberrantly expressed self-antigens, mutated self-antigens, and tumor-specific antigens, providing targets for therapeutic interventions. Various studies have identified nucleic acid sequences expressed in cancers, such as gastrointestinal, kidney, and prostate cancers, which can be utilized for cancer identification and treatment. Monoclonal antibodies targeting specific epitopes on tumor antigens have been developed for diagnostic and therapeutic purposes in human cancers. Novel cancer-associated antigens have been discovered, along with their amino acid and nucleic acid sequences, binding proteins, and immunoconjugates, offering new avenues for cancer diagnosis and treatment. The diverse array of antigens recognized by tumor-reactive T cells presents both opportunities and challenges for developing more effective cancer immunotherapies.